Neurological

An experimental drug has been shown to slow the progression and prolong survival of patients suffering from the neurodegenerative disease ALS. With Phase 2 human trials complete, the company developing the treatment is working to accelerate its approval.

Tinnitus is an aggravating disorder, causing sufferers to constantly hear a ringing in their ears. A new system could help, though, by simultaneously zapping their tongue and delivering sounds to their ears.

Stem cells could help treat a variety of diseases. A new study has found that transplanting neurons grown from stem cells into the brains of mice with Parkinson’s disease repaired the damaged brain circuits, improving the animals’ motor skills.

Preliminary research has discovered several blood-based biomarkers which can specifically indicate stroke damage to brain tissue. The goal of the research is to develop a simple blood test to rapidly detect whether a patient is suffering a minor stroke.

A new article from a team of neuroscientists is warning a future ‘silent wave’ of neurodegenerative disease may be spawned by the COVID-19 pandemic. The researchers suggest the SARS-CoV-2 virus can increase a person’s risk of developing Parkinson’s disease.

A study has homed in on the brain circuit responsible for stress-induced insomnia. The research suggests this same circuit is responsible for stress-related immune system dysfunction, pointing to a close relationship between stress, insomnia and weakened immunity.

A new study, led by researchers from University College London, is offering some of the first robust evidence showing how CBD, a key compound in cannabis, increases cerebral blood flow in memory processing regions of the brain such as the hippocampus.

Scientists investigating Alzheimer’s treatments at the Salk Institute have uncovered some key mechanisms that enable an experimental drug to reverse memory loss in mouse models of the disease, offering new targets for researchers in the field.

Scientists in Australia have made an exciting breakthrough in Alzheimer’s research, demonstrating what they describe as the first gene-therapy-based approach for treating advanced forms of the disease.

Research into Alzheimer’s diagnostic technologies has highlighted the potential of a new biomarker in the blood, which was shown to distinguish healthy patients from early asymptomatic Alzheimer’s patients with a high degree of accuracy.

A new study investigating brain activity patterns in schizophrenia patients and their siblings is suggesting a specific brain “signature” could detect the condition in subjects before clinical symptoms appear.

An intriguing study has identified a protein produced by the liver after exercise that could protect the brain from cognitive decline. The study points to the possibility of developing a drug to generate this same effect without the need for exercise.